CD274 and lung adenocarcinoma: Moreover, PD-1/PD-L1 inhibition in an orthotopic murine model of lung adenocarcinoma demonstrated that cancer cells expressing MHC II were sensitive to immune checkpoint inhibition whereas MHC II negative lung cancer was resistant (27).